Fabian Schnitzler

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Patients With Inflammatory Bowel Disease

Prognostic Factors

Coronary Artery Bypass

Ejection Fraction

Top Venues

Crohn's & colitis 360

Canadian journal of gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian Schnitzler, Cornelia Tillack-Schreiber, Daniel Szokodi, Isabel Braun, June Tomelden, Maximilian Sohn, Franz Bader, Constanze Heike Waggershauser, Thomas Ochsenkühn
Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center. PloS one 19 (1) (2024)
Fabian Schnitzler, Cornelia Tillack-Schreiber, Daniel Szokodi, Isabel Braun, June Tomelden, Maximilian Sohn, Franz Bader, Constanze Heike Waggershauser, Thomas Ochsenkühn
Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center. PloS one 19 (1) (2024)
Fabian Schnitzler, Cornelia Tillack-Schreiber, Daniel Szokodi, Isabel Braun, June Tomelden, Maximilian Sohn, Franz Bader, Constanze Heike Waggershauser, Thomas Ochsenkühn
Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center. PloS one 19 (1) (2024)
Constanze Heike Waggershauser, Cornelia Tillack-Schreiber, Paul Weyh, Eckhard U Alt, Thorsten Siegmund, Christine Berchthold-Benchieb, Daniel Szokodi, Fabian Schnitzler, Thomas Ochsenkühn
Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD Patients. Canadian journal of gastroenterology & hepatology 2022 (2022)
Fabian Schnitzler, Theresia Seitz, Cornelia Tillack-Schreiber, Silke Lange, Constanze Waggershauser, Thomas Ochsenkühn
Early Start of Infliximab in Crohn's Disease Increases Rates of Endoscopic Remission and Decreases Stenosis Formation: Experiences From a Single Center Cohort. Crohn's & colitis 360 3 (3) (2021)
Fabian Schnitzler, Theresia Seitz, Cornelia Tillack-Schreiber, Silke Lange, Constanze Waggershauser, Thomas Ochsenkühn
Early Start of Infliximab in Crohn's Disease Increases Rates of Endoscopic Remission and Decreases Stenosis Formation: Experiences From a Single Center Cohort. Crohn's & colitis 360 3 (3) (2021)
Fabian Schnitzler, Matthias Friedrich, Marianne Angelberger, Julia Diegelmann, Johannes Stallhofer, Christiane Wolf, Joel Dütschler, Samuel Truniger, Torsten Olszak, Florian Beigel, Cornelia Tillack, Peter Lohse, Stephan Brand
Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn's disease and active smoking status resulting in ileal stenosis requiring surgery. PloS one 15 (7) (2020)